Related Experiment Video
Updated: Jan 30, 2026
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Multiple Defects Sensitize p53-Deficient Head and Neck Cancer Cells to the WEE1 Kinase Inhibition
Ahmed Diab1, Michael Kao2, Keffy Kehrli3
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Abstract:
The p53 gene is the most commonly mutated gene in solid tumors, but leveraging p53 status in therapy remains a challenge. Previously, we determined that p53 deficiency sensitizes head and neck cancer cells to AZD1775, a WEE1 kinase inhibitor, and translated our findings into a phase I clinical trial. Here, we investigate how p53 affects cellular responses to AZD1775 at the molecular level. We found that p53 modulates both replication stress and mitotic deregulation triggered by WEE1 inhibition. Without p53, slowing of replication forks due to replication stress is exacerbated. Abnormal, γH2AX-positive mitoses become more common and can proceed with damaged or underreplicated DNA. p53-deficient cells fail to properly recover from WEE1 inhibition and exhibit fewer 53BP1 nuclear bodies despite evidence of unresolved damage. A faulty G1-S checkpoint propagates this damage into the next division. Together, these deficiencies can intensify damages in each consecutive cell cycle in the drug. IMPLICATIONS: The data encourage the use of AZD1775 in combination with genotoxic modalities against p53-deficient head and neck squamous cell carcinoma.
Insights
p53 deficiency exacerbates DNA damage in head and neck cancer cells treated with WEE1 inhibitor AZD1775. This suggests combining AZD1775 with genotoxic therapies for p53-deficient tumors.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- The p53 gene is frequently mutated in solid tumors, posing therapeutic challenges.
- p53 deficiency has been linked to increased sensitivity to WEE1 kinase inhibitors like AZD1775.
Purpose of the Study:
- To elucidate the molecular mechanisms by which p53 status influences cellular responses to AZD1775.
- To understand how p53 deficiency impacts replication stress and mitotic control under WEE1 inhibition.
Main Methods:
- Investigated cellular responses to AZD1775 in p53-deficient versus p53-proficient head and neck cancer cells.
- Analyzed replication fork dynamics, mitotic abnormalities (γH2AX staining), and DNA damage response markers (53BP1 nuclear bodies).
- Assessed checkpoint function (G1-S) and damage propagation across cell cycles.
Main Results:
- p53 deficiency worsens replication fork stalling and increases abnormal mitoses with unrepaired DNA after AZD1775 treatment.
- p53-deficient cells show impaired recovery and reduced 53BP1 nuclear bodies despite persistent DNA damage.
- A defective G1-S checkpoint in p53-deficient cells leads to accumulation of damage in subsequent cell cycles.
Conclusions:
- p53 plays a crucial role in managing replication stress and mitotic integrity during WEE1 inhibition.
- The findings support the combination of AZD1775 with genotoxic agents for treating p53-deficient head and neck squamous cell carcinoma.
Related Concept Videos
01:26Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
01:19Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
02:54Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
02:54Protein Kinases and Phosphatases
00:46Feedback Inhibition
01:26Muscles of the Anterior Neck